--- url: 'https://qubit.capital/blog/uk-series-a-weekly-funding-roundup-week-2-april-2026' title: 'UK Series A Weekly Funding Roundup (Apr 7-14, 2026): $47.0M Raised Across 2 Deals' author: name: Vaibhav Totuka url: 'https://qubit.capital/blog/author/vaibhav-totuka' date: '2026-04-14T05:09:21+05:30' modified: '2026-04-14T11:31:59+05:30' type: post summary: 'Two London startups raised $47M in Series A funding this week. JAAQ secured $17M for digital health, while Origin pulled in $30M for HR technology.' categories: - Weekly Funding Roundup image: 'https://qubit.capital/wp-content/uploads/2026/04/featured-uk-series-a-65718.webp' published: true --- # UK Series A Weekly Funding Roundup (Apr 7-14, 2026): $47.0M Raised Across 2 Deals London’s Series A market stayed active this week as two startups pulled in a combined $47 million. A digital health platform and an HR technology company each closed sizable rounds, reflecting continued investor appetite for vertical software that tackles entrenched operational pain points in healthcare and human resources. Both rounds share a common thread: replacing fragmented, manual processes with unified platforms. The deals also signal that UK investors remain willing to back companies at meaningful scale when the category is large and the incumbents are slow. Here’s what happened. Weekly Funding Roundup APR 7-14, 2026 $47M TOTAL RAISED 2DEALS CLOSED MixedSTAGE $23.5MAVG DEAL SIZE UKTOP REGION BY STAGE Series A+ (Extended)$30M64% Series A$17M36% BY SECTOR OriginSaaS / HR Technology$30M JAAQHealthtech$17M Table of Contents - [1. JAAQ Raises $17M for Digital Health Platform](#1-jaaq-raises-$17m-for-digital-health-platform) [Deal Overview](#deal-overview) - [Investor Profile](#investor-profile) - [Company and Leadership](#company-and-leadership) - [Problem and Opportunity](#problem-and-opportunity) - [Product and Technology](#product-and-technology) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision) - [Market Context](#market-context) - [2. Origin Raises $30M for HR Technology](#2-origin-raises-$30m-for-hr-technology) [Deal Overview](#deal-overview-1) - [Investor Profile](#investor-profile-1) - [Company and Leadership](#company-and-leadership-1) - [Problem and Opportunity](#problem-and-opportunity-1) - [Product and Technology](#product-and-technology-1) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-1) - [Market Context](#market-context-1) - [Lessons For Founders](#lessons-for-founders) ## 1. JAAQ Raises $17M for Digital Health Platform ### Deal Overview - **Stage:** Series A - **Sector:** Healthtech - **Geography:** London, United Kingdom - **Round size:** $17M (£13M) ### Investor Profile The round was backed by Meridian Health Ventures, Fuel Ventures, Bolt Angels, and Guinness Ventures. Fuel Ventures has built a reputation as one of the UK’s more active early-stage funds, while Guinness Ventures brings a long track record in tax-efficient venture investing. Meridian’s involvement points to specialist healthcare conviction, and Bolt Angels adds an operator-driven angel network to the cap table. ### Company and Leadership [JAAQ](https://www.jaaq.health) is a London-based startup building a clinically governed digital health and engagement platform. The company has focused on bridging the gap between clinical oversight and digital delivery, an area where many consumer health apps fall short on governance and many NHS tools fall short on user experience. ### Problem and Opportunity Health systems across the UK face mounting pressure to deliver more care digitally while maintaining clinical standards. Most existing digital tools are either clinician-facing (EHRs, scheduling) or consumer-facing (wellness apps) with little crossover. JAAQ targets the middle ground: structured digital health engagement that meets clinical governance requirements. The NHS Long Term Plan’s push toward digital-first delivery creates a natural tailwind. ### Product and Technology JAAQ’s platform enables organizations to deliver clinically governed health content and engagement programs through digital channels. The clinical governance layer is the differentiator. Rather than generic wellness content, the platform ensures that health information and pathways meet regulatory and clinical standards before reaching users. This makes it usable by NHS trusts and private providers who can’t risk non-compliant content reaching patients. ### Use of Proceeds and Vision The £13M raise will go toward scaling the platform across more health systems and expanding the range of clinical pathways available. JAAQ’s ambition is to become the default infrastructure for clinically safe digital health engagement in the UK, with potential to expand into other regulated healthcare markets. ### Market Context The UK digital health market is projected to exceed $15 billion by 2028. The NHS is the single largest buyer, and its procurement cycles are long but sticky once a vendor is embedded. Competitors range from large EHR vendors adding patient engagement features to smaller digital therapeutics startups. JAAQ’s clinical governance positioning carves out a distinct lane. ## 2. Origin Raises $30M for HR Technology ### Deal Overview - **Stage:** Series A+ (Extended) - **Sector:** SaaS / HR Technology - **Geography:** London, United Kingdom - **Round size:** $30M ### Investor Profile Investor details for this extended Series A+ round have not been publicly disclosed. The $30M size for a UK HR tech company at this stage suggests participation from growth-oriented European or transatlantic funds comfortable with the HR software category. ### Company and Leadership [Origin](https://www.originhr.com) is a London-based HR technology startup that has been building a platform to modernize how companies manage their people operations. The extended round structure, topping up an earlier Series A, indicates the company hit milestones that justified additional capital before a full Series B. ### Problem and Opportunity HR departments at mid-market and scaling companies typically cobble together five to ten different tools for payroll, benefits, onboarding, compliance, and performance management. Each system holds a slice of employee data, and none talk to each other well. The result is manual work, compliance risk, and poor employee experience. This fragmentation gets worse as companies expand across borders, which many UK-based startups do early. ### Product and Technology Origin’s platform consolidates core HR functions into a single system. The value proposition is straightforward: one place for employee data, one workflow engine for HR processes, and one interface for both HR teams and employees. For UK and European companies, built-in compliance with local employment regulations is table stakes. Origin’s ability to handle multi-country complexity is a key draw for its target market of scaling businesses. ### Use of Proceeds and Vision The $30M will fund platform development and go-to-market expansion. Origin is scaling its HR platform to serve a broader base of mid-market companies, with a focus on those operating across multiple geographies. The extended round gives the company runway to reach metrics that support a strong Series B. ### Market Context The global HR technology market is valued at over $30 billion and growing at roughly 10% annually. In Europe, the competitive set includes Personio (valued at $8.5B in 2022, though marked down since), HiBob, and legacy players like SAP SuccessFactors and Workday. The mid-market segment remains underserved by tools that handle European regulatory complexity without enterprise-level pricing. Origin’s $30M raise positions it to compete seriously in that gap. ## Lessons For Founders - **Clinical governance is a product feature, not a checkbox.** JAAQ turned regulatory compliance into its core differentiator. In regulated industries like healthcare, building governance into the product from day one creates barriers that competitors bolting it on later will struggle to match. - **Extended rounds signal smart capital timing.** Origin’s Series A+ structure shows that raising incremental capital at proven milestones can be more effective than jumping straight to a large Series B. It preserves optionality and reduces dilution risk if market conditions shift. - **Fragmented workflows remain a reliable funding thesis.** Both companies target sectors where professionals still stitch together multiple tools and manual processes. If your target user has five browser tabs open to do one job, there’s a platform opportunity. - **UK investors back vertical software with clear buyers.** Neither of these rounds required exotic technology claims. Both pitched a defined buyer (health systems, HR leaders), a real workflow problem, and a product that solves it. Clarity of customer and use case still wins rounds.